Zdrowie i gospodarka · 5.08.1997
Bio-Components, Inc.; Revocation of U.S. License No. 1160
The Food and Drug Administration (FDA) is announcing the revocation of U.S. License No. 1160, which includes the establishment license and the product licenses for the manufacture of Source Plasma and Source Leukocytes, issued to Bio-Components, Inc. (BCI). BCI did not respond to a notice of opportunity for a hearing on a proposal to revoke its licenses.